Neuropsikofarmakologia Ikerketa Taldea

• DelaCuesta-Barrutia J, Peñagarikano O, Ramos-Miguel A, Erdozain AM  Polymorphisms in GPCR genes: Their role in schizophrenia, autism diseases and response to antipsychotic treatment - A systematic review Progress in Neuro-Psychopharmacology and Biological Psychiatry,  2026;  146:111669
• Erkizia-Santamaría I, Fernández L, Horrillo I, Meana JJ, Ortega JE  Comparative analysis of multiple chronic unpredictable mild stress paradigms in mice: Behavioural and physiological validity Neurobiology Stress,  2026;  42: 100815
• Hernández-Hernández E, Ledesma-Corvi S, Yáñez-Gómez F, Mateu-Mercader N, Bagán A, Escolano C, García-Fuster MJ  Sex differences in the antidepressant- like response induced by the imidazoline-2 receptor compound 12d, a (3-phenylcarbamoyl-3,4-dihydro‑2H‑pyrrol-2-yl)phosphonate Pharmacological Reports,  2026;  78(1),  341 - 349
• Sánchez Milán JA, Mulet M, Molet I, Lisa-Molina J, Font-Alberich M, Lorca C, Gea-Sánchez M, Bellon F, Batalla I, Meana JJ, Callado LF, Morentin B, Ramos- Miguel A, Kalaria RN, Serra A, Gallart-Palau X  Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia Acta neuropathologica communications,  2026;  14(1):41
• Unzueta-Larrinaga P, Cuesta-Vega E, Barrena-Barbadillo R, Olabarrieta E, Recio-Barbero M, Horrillo I, Mentxaka O, Segarra R, Meana JJ, Nacher J, Diez- Alarcia R, Callado LF, Urigüen L  Extracellular matrix dysfunction and synaptic alterations in schizophre Molecular Psychiatry,  2026;  31(1),  396 - 406